1-3 of 3
Jason A. Castellanos
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer

Nagaraj S. Nagathihalli, Jason A. Castellanos, Purushottam Lamichhane, Fanuel Messaggio, Chanjuan Shi, Xizi Dai, Priyamvada Rai, Xi Chen, Michael N. VanSaun, Nipun B. Merchant
Journal: Cancer Research
Series: Author Choice
Cancer Res (2018) 78 (21): 6235–6246.
https://doi.org/10.1158/0008-5472.CAN-18-0634
Published: 01 November 2018
View article titled, Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer
Open the PDF for Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer in another window
Journal Articles

Abstract A46: AdipoRon suppresses ERK and STAT3 to inhibit pancreatic cancer growth

Fanuel Messaggio, Alisha M. Mendonsa, Jason A. Castellanos, Casey Roberts, Nagaraj S. Nagathihalli, Nipun B. Merchant, Lee D. Gorden, Michael N. VanSaun
Journal: Cancer Research
Cancer Res (2016) 76 (24_Supplement): A46.
https://doi.org/10.1158/1538-7445.PANCA16-A46
Published: 14 December 2016
View article titled, Abstract A46: AdipoRon suppresses ERK and STAT3 to inhibit pancreatic cancer growth
Journal Articles

Abstract 2537: CDK4/6 inhibition synergizes with KRAS-MAPK pathway targeting in pancreatic cancer

Jason A. Castellanos, Nagaraj Nagathihalli, Michael N. Van Saun, Cameron Kasmai, Yanhua Xiong, Nipun Merchant
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 2537.
https://doi.org/10.1158/1538-7445.AM2015-2537
Published: 01 August 2015
View article titled, Abstract 2537: CDK4/6 inhibition synergizes with KRAS-MAPK pathway targeting in pancreatic cancer